News
EMBC INVESTOR DEADLINE: Embecta Corp. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit-- HBSS
SAN FRANCISCO, July 14, 2026 /PRNewswire/ -- Embecta Corp. (NASDAQ: EMBC) faces a securities class action lawsuit, which seeks to represent investors who purchased or acquired Embecta common stock bet
Crescent Biopharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants
WALTHAM, Mass., July 14, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next
Crescent Biopharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants
WALTHAM, Mass. , July 14, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. ("Crescent" or the "Company") (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next
ERAS INVESTOR DEADLINE: Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - HBSS
SAN FRANCISCO, July 14, 2026 /PRNewswire/ -- Erasca, Inc. (NASDAQ: ERAS) faces a securities class action after the stock tanked $9.25 (-48%) on news that Revolution Medicines (RevMed) accused Erasca o
INVESTOR DEADLINE: Verra Mobility Corp. (VRRM) Investors with Substantial Losses Have Opportunity to Lead the Verra Mobility Class Action Lawsuit- HBSS
SAN FRANCISCO, July 14, 2026 /PRNewswire/ -- Hagens Berman (HBSS), a securities litigation leader, is broadening its investigation into Verra Mobility Corp. (NASDAQ: VRRM) following the company's disc
INVESTOR NOTICE: PicS (PICS) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action- HBSS
SAN FRANCISCO, July 14, 2026 /PRNewswire/ -- Hagens Berman, a recognized leader in securities litigation, is actively investigating claims pled in an investor class action alleging that PicS N.V. (NAS
INVESTOR NOTICE: GRAIL, Inc. (GRAL) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action- Hagens Berman
SAN FRANCISCO, July 14, 2026 /PRNewswire/ -- On February 20, 2026, GRAIL, Inc. (NASDAQ: GRAL) shed over $2.2 billion of market capitalization after surprising investors with its NHS-Galleri Trial read
VERI INVESTOR NOTICE: Veritone, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - HBSS
SAN FRANCISCO, July 14, 2026 /PRNewswire/ -- National shareholder rights firm Hagens Berman (HBSS) is actively investigating claims alleged against Veritone, Inc. (NASDAQ: VERI) and certain of its exe
SRAD 3-DAY DEADLINE ALERT: HBSS Investigates Sportradar Group AG (SRAD) Securities Class Action Claims After Short Seller Reports Expose Alleged Illegal Gambling Ties
SAN FRANCISCO, July 14, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP (HBSS), a leading national securities litigation firm, is investigating claims in a securities class action lawsuit against
CVLT 3-DAY DEADLINE ALERT: Commvault (CVLT) Investors Alerted to Securities Class Action, Encouraged to Contact HBSS
SAN FRANCISCO, July 14, 2026 /PRNewswire/ -- Hagens Berman (HBSS), a national shareholder rights firm, alerts investors in Commvault Systems, Inc. (NASDAQ: CVLT) that a newly filed securities class ac
Barclays Investor News: If You Have Suffered Losses in Barclays PLC (NYSE: BCS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barclays PLC (NYSE
Barclays Investor News: If You Have Suffered Losses in Barclays PLC (NYSE: BCS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barclays PLC (NYSE
CancerVax Develops Novel Smart mRNA to Harness Pre-Existing Immunity in 99% of World Population
Lehi, Utah, July 14, 2026 (GLOBE NEWSWIRE) -- Lehi, Utah, July 14, 2026 - CancerVax, Inc. , the developer of a breakthrough universal cancer treatment platform that "tricks" the body's immune system i
WGA filing lawsuit to block Paramount's $81B WBD merger in latest acquisition challenge
The union argued that the merger would create less competitors and give the larger company “both the incentive and the ability” to lower wages and the number of projects that offer workers employment.
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif. , July 14, 2026 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentia
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potential
OpenAI's First Device Will Reportedly Be a Portable Smart Speaker
The device is expected to possess a "personality" that will serve as a "humanlike AI companion," Bloomberg reports.
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
Miles Wang, an OpenAI researcher whose work includes using AI to accelerate scientific and biological discovery, is leaving the ChatGPT maker to launch a new startup focused on developing AI models fo
Trenchant Technologies Capital Corp. Announces Closing of First Tranche of the Private Placement of Convertible Debentures
Toronto, Ontario--(Newsfile Corp. - July 14, 2026) - Trenchant Technologies Capital Corp. (CSE: AITT) (OTC Pink: AITTF) ("Trenchant" or the "Company") is pleased to announce that, further to its news
Celebrus Technologies plc (DFORF) Q4 2026 Earnings Call Transcript
Celebrus Technologies plc (DFORF) Q4 2026 Earnings Call Transcript
